Peptides
MAZDUTIDE 10 MG
DUAL GLUCAGON AGONIST; GLP-1 AGONIST
ACTIVE SUBSTANCE: 10 MG MAZDUTIDE
FORM: 2 ML VIAL
ACTIVE HALF-LIFE: 158-180 HOURS
DOSAGE: MEN 3-9 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
100.00 USD
Shipping From:
International
U.S. Domestic
MAZDUTIDE 10 MG Detailed
Clinically Trusted Mazdutide 10mg by Dragon Pharma
[store name] is your certified source for advanced weight loss and metabolic peptides. We offer only original Dragon Pharma products, including the powerful Mazdutide 10mg formulation.
What is Mazdutide?
Mazdutide is a cutting-edge dual GLP-1 and glucagon receptor agonist developed by Dragon Pharma. Each 2 mL vial contains 10 mg of Mazdutide, designed to target obesity, insulin resistance, and energy dysregulation. By mimicking and activating GLP-1 and glucagon receptors, it helps suppress appetite, increase metabolic rate, and improve glycemic control—making it especially valuable for individuals struggling with body fat reduction and type 2 diabetes.
How Does Mazdutide Work?
Mazdutide works by simulating the effects of two key metabolic hormones:
- GLP-1 Activation: Slows gastric emptying, increases satiety, and promotes insulin release.
- Glucagon Receptor Activation: Boosts energy expenditure and enhances lipolysis.
This dual approach supports profound weight loss and fat metabolism over time. When paired with other fat loss compounds like AOD 9604, it can further enhance transformation cycles.
Suggested Mazdutide Cycle
An effective Mazdutide cycle typically spans 12–16 weeks:
- Weeks 1–4: 3 mg/week (initiation phase)
- Weeks 5–8: 6 mg/week (titration phase)
- Weeks 9+: 9–10 mg/week (maintenance)
Incorporating growth hormone peptides or L-Carnitine may further accelerate body composition improvements. Dosage should always be tailored by a healthcare professional.
Potential Side Effects
Most side effects occur early in treatment and include:
- Nausea, bloating, or mild abdominal discomfort
- Decreased appetite (intended effect)
- Dizziness or lightheadedness during dose escalation
These reactions often fade as the body adapts. Users with kidney or liver concerns should be monitored by a healthcare provider.
Lab Testing & Safety
Mazdutide 10mg by Dragon Pharma is fully lab-tested to ensure purity and clinical-grade formulation. Our lab-tested selection reinforces our position as a Dragon Pharma products lineup leader.
Why Choose Mazdutide?
Backed by early-phase clinical studies and innovation in GLP-1 research, Mazdutide offers a novel solution for long-term metabolic improvement. It is especially valuable for athletes in cutting phases or individuals seeking sustained appetite control and leaner body mass.
Explore more transformative peptides and metabolic agents in our full catalog.
Frequently Asked Questions about Mazdutide 10mg
What is the main benefit of using Mazdutide?
Mazdutide supports weight loss and improves metabolic health by activating both GLP-1 and glucagon receptors, leading to appetite suppression and increased fat burning.
How do you dose Mazdutide safely?
Start with 3 mg per week for the first 4 weeks, then increase to 6–10 mg weekly based on tolerance and goals. Always follow healthcare provider guidance for safe escalation.
Do I need a post-cycle therapy (PCT) with Mazdutide?
No, Mazdutide does not suppress natural testosterone or hormone production, so PCT is not required.
Is Mazdutide safe to stack with other peptides or fat burners?
Yes, it is often stacked with peptides like AOD 9604 or growth hormone analogs. Consult a medical professional to tailor the stack to your goals and ensure safety.
No reviews found
Please log in to write MAZDUTIDE 10 MG review.
Related Offers
Lab Tested
US Domestic & International
Dragon Pharma, Europe
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~7 DAYS
DOSAGE: 0.25 - 0.5 MG/WEEK
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HIGH BLOOD PRESSURE (HBP)): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
70.00 USD
Coming Soon!
Dragon Pharma, Europe
CLASSIFICATION: HUMAN PEPTIDE HORMONE
ACTIVE SUBSTANCE: GHK-CU
FORM: 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: ~ 30 MINUTES
DOSAGE: 2-3 TIMES PER WEEK
ACNE: NOT REPORTED
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NO KNOWN IMPACT
HEPATOTOXICITY: NONE
AROMATIZATION: DOES NOT AROMATIZE
MANUFACTURER: DRAGON PHARMA
Coming Soon!
Dragon Pharma, Europe
CLASSIFICATION: FAT-BURNING PEPTIDE (GH FRAGMENT)
ACTIVE SUBSTANCE: AOD9604 (Fragment 176-191)
FORM: 2 mL VIAL × 5 MG
ACTIVE HALF-LIFE: ~4 HOURS
DOSAGE: MEN/WOMEN – 300–500 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
Lab Tested
US Domestic & International
Dragon Pharma, Europe
CLASSIFICATION: GIP/GLP-1/GLUCAGON RECEPTOR TRIAGONIST
ACTIVE SUBSTANCE: RETATRUTIDE
FORM: 2 ML VIAL x 10 MG
ACTIVE HALF-LIFE: ~ 6 DAYS
DOSAGE: 0.5 MG/WEEK
ACNE: N/A
WATER RETENTION: N/A
HIGH BLOOD PRESSURE (HBP): N/A
HEPATOTOXICITY: N/A
AROMATIZATION: N/A
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
145.00 USD
Lab Tested
US Domestic & International
Dragon Pharma, Europe
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HIGH BLOOD PRESSURE (HBP)): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA, EUROPE
LABORATORY TESTED: VIEW LAB RESULTS
90.00 USD